Evidence map›Paper›PMID 33425991›Full record

ArticleFrontiers in molecular biosciences2020

Hierarchical Graph Representation of Pharmacophore Models.

Garon Arthur, Wieder Oliver, Bareis Klaus, Seidel Thomas, Ibis Gökhan, Bryant Sharon, Theret Isabelle, Ducrot Pierre, Langer Thierry

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Garon ArthurDepartment of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Wieder OliverDepartment of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Bareis KlausDepartment of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Seidel ThomasDepartment of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Ibis GökhanInte:Ligand Software-Entwicklungs und Consulting GmbH, Vienna, Austria.
Bryant SharonInte:Ligand Software-Entwicklungs und Consulting GmbH, Vienna, Austria.
Theret IsabelleInstitut de Recherches Servier (IdRS), Croissy-sur-Seine, France.
Ducrot PierreDepartment of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Langer ThierryDepartment of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
University of Vienna · ATInte:Ligand (Austria) · ATInstitut des Hautes Études Scientifiques · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the investigation of protein-ligand interaction patterns, the current accessibility of a wide variety of sampling methods allows quick access to large-scale data. The main example is the intensive use of molecular dynamics simulations applied to crystallographic structures which provide dynamic information on the binding interactions in protein-ligand complexes. Chemical feature interaction based pharmacophore models extracted from these simulations, were recently used with consensus scoring approaches to identify potentially active molecules. While this approach is rapid and can be fully automated for virtual screening, additional relevant information from such simulations is still opaque and so far the full potential has not been entirely exploited. To address these aspects, we developed the hierarchical graph representation of pharmacophore models (HGPM). This single graph representation enables an intuitive observation of numerous pharmacophore models from long MD trajectories and further emphasizes their relationship and feature hierarchy. The resulting interactive depiction provides an easy-to-apprehend tool for the selection of sets of pharmacophores as well as visual support for analysis of pharmacophore feature composition and virtual screening results. Furthermore, the representation can be adapted to include information involving interactions between the same protein and multiple different ligands. Herein, we describe the generation, visualization and use of HGPMs generated from MD simulations of two x-ray crystallographic derived structures of the human glucokinase protein in complex with allosteric activators. The results demonstrate that a large number of pharmacophores and their relationships can be visualized in an interactive, efficient manner, unique binding modes identified and a combination of models derived from long MD simulations can be strategically prioritized for VS campaigns.

Indexed as

clusteringhierarchical graph representationhuman glucokinasemolecular dynamic (MD) simulationpharmacophore modelingprotein ligand bindingprotein structurevirtual screening

Identifiers

PMID33425991
PMCPMC7793842
OpenAlexW3112126107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.